Small regulatory RNAs and skeletal muscle cell differentiation

Abstract

Until recently, RNA was considered to be merely a downstream effector of the "noble" genome, the latter having all the information and therefore occupying a position at the very heart of gene regulation, according to the "central dogma" of DNA transcribed into RNA translated into protein. Although we all knew that RNAs also have accessory functions, and that non-coding RNAs intervene at all stages of gene expression, these essential functions were considered to be mere "housekeepers," and RNA was denied a regulatory role. This dogma was, however, "blown up" several years ago by the concomitant discovery of RNA interference and microRNAs in a model organism, the worm Caenorhabditis elegans. We now know that small regulatory RNAs are widely conserved in plants and animals, and that microRNAs and short interfering RNAs are not the only kinds of regulatory small RNAs that exist. Indeed, the variety of functions in which small non-coding RNAs have been shown to play essential roles has grown rapidly. Basically, they are involved in controlling large genetic programs or large regions of cell genomes, and they participate in determining what is called cell fate, or the balance between cell proliferation, differentiation and death. This equilibrium is strictly controlled under normal conditions, and its deregulation leads to oncogenesis. One of our main interests is the function of microRNAs in mammalian skeletal muscle. We describe here the high-throughput screening strategy used in our laboratory to identify and validate the microRNAs and their specific targets which are essential for muscle cell differentiation. © Springer-Verlag Berlin Heidelberg 2013.